title: Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina.
abstract: BACKGROUND
  Glycosylated hemoglobin A1C (HbA1c) has been widely recognized as a marker for predicting the severity of diabetes mellitus (DM) and several cardiovascular diseases. However, whether HbA1c could predict the severity and clinical outcomes in patients with stable coronary artery disease (CAD) remains largely unknown. We determine relationship of HbA1c with severity and outcome in patients with stable CAD.
  
  
  METHODS
  We enrolled 1433 patients with stable angina who underwent coronary angiography and were followed up for an average 12 months. The patients were classified into three groups by tertiles of baseline HbA1c level (low group <5.7%, n = 483; intermediate group 5.7 - 6.3%, n = 512; high group >6.3%, n = 438). The relationships between the plasma HbA1c and severity of CAD and early clinical outcomes were evaluated.
  
  
  RESULTS
  High HbA1c was associated with three-vessel disease. Area under the receivers operating characteristic curve (AUC = 0.67, 95% CI: 0.63-0.71, P < 0.001) and multivariate logistic regression analysis suggested that HbA1C was an independent predictor of severity of CAD (OR = 1.60, 95% CI: 1.29-1.99, P < 0.001) even after adjusting for gender, age, risk factor of CAD, lipid profile and fasting blood glucose. During follow-up, 133 patients underwent pre-specified outcomes. After adjusting for multiple variables in the Cox regression model, HbA1C remained to be an independent predictor of poor prognosis (HR = 1.28, 95% CI: 1.12-1.45, P < 0.001).
  
  
  CONCLUSIONS
  We concluded that high level of baseline HbA1c appeared to be an independent predictor for the severity of CAD and poor outcome in patients with stable CAD.
authors.forename: Li-Feng
authors.initials: LF
authors.lastname: Hong
authors.forename: Xiao-Lin
authors.initials: XL
authors.lastname: Li
authors.forename: Yuan-Lin
authors.initials: YL
authors.lastname: Guo
authors.forename: Song-Hui
authors.initials: SH
authors.lastname: Luo
authors.forename: Cheng-Gang
authors.initials: CG
authors.lastname: Zhu
authors.forename: Ping
authors.initials: P
authors.lastname: Qing
authors.forename: Rui-Xia
authors.initials: RX
authors.lastname: Xu
authors.forename: Na-Qiong
authors.initials: NQ
authors.lastname: Wu
authors.affiliation: Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China. lijianjun938@yahoo.com.
authors.forename: Jian-Jun
authors.initials: JJ
authors.lastname: Li
mesh_terms: D060050:Angina, Stable / Q000097:blood* / Q000473:pathology*; D003324:Coronary Artery Disease / Q000097:blood* / Q000473:pathology*; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D011446:Prospective Studies
chemical_list: D006442:Glycated Hemoglobin